The plasma triacylglycerol-decreasing effect of fish-oil fatty acids was studied in vitro by using the rapidly growing cultured rat hepatoma cell line McA-RH7777. Cells were exposed to albumin-complexed eicosapentaenoic acid (C20:5n-3; EPA), to oleic acid (Cl8 .1_,; OA), or to albumin alone. Cell growth was similar in albumin-and OA-supplemented cultures, but EPA treatment inhibited growth. As estimated by [14C]glycerol incorporation, OA stimulated both net triacylglycerol synthesis and secretion over control levels in a dose-dependent manner. EPA stimulated triacylglycerol synthesis in similar fashion to OA, but paradoxically decreased net triacylglycerol secretion and led to exaggerated intracellular accumulation of radiolabelled triacylglycerol. The EPA and OA effects were additive at low concentrations of total fatty acid, but at higher fatty acid concentrations OA appeared to negate some effects of EPA. Chemical analysis of albumin-and OAtreated cultures revealed OA-dominant profiles for both cellular and medium triacylglycerol-associated fatty acids. In contrast, EPA was the principal fatty acid in cellular triacylglycerol of EPA-supplemented cultures, whereas medium triacylglycerol from these cultures contained very little EPA. We conclude that McA-RH7777 hepatoma cells readily synthesize EPA-containing triacylglycerol molecules, but they have variable capacity for secreting them. We consider potential mechanisms to account for the effects of EPA in this system.
INTRODUCTION
The n -3 or w -3 series of polyunsaturated fatty acids (PUFAs) exert pleiotropic effects on biological systems. They have found widespread and often controversial application in medicine, ranging from alleviation of dermatological maladies [1] to the dietary and pharmacological management of diabetes mellitus [2] , renal disorders [3] , inflammatory bowel disease [4] and cardiovascular disease [5] . Human populations that regularly consume ocean fish exhibit low rates of cardiovascular disease, especially in combination with a diet low in saturated fat content [6] . Fish-oil fatty acids of the n -3 series may exert a protective influence beyond that associated with other types of polyunsaturates, as suggested by retrospective cohort analyses showing an inverse relationship between fish consumption and ischaemic heart disease [7] . Reported beneficial effects of fish-oil n -3 PUFAs include altered vascular tone, decreased coagulability of blood, and changes in plasma lipoprotein metabolism [5] .
Authors have generally concluded that fish-oil n -3 PUFAs lower plasma triacylglycerol concentrations in many species, including humans [5, [8] [9] [10] [11] . The n -3 PUFAs effectively lower plasma triacylglycerol in normotriglyceridaemic [12] and in both transiently [13] and chronically [14, 15] hypertriglyceridemic subjects. Turnover studies have shown that n-3 PUFAs decrease very-low-density lipoprotein (VLDL) production in vivo in animals [8, 16] and humans [17, 18] . Decreased VLDL production has also been documented ex vivo in perfused rat livers [19, 20] and in primary cultures of rat hepatocytes [21, 22] .
The Morris hepatoma 7777 and its cultured derivative McA-RH7777 [23] have been used extensively for biochemical and morphological studies since 1968 (summarized in [24] ). Both the solid tumour and the cultured cells actively synthesize and secrete plasma lipoproteins [25, 26] . Previous work in our laboratory has focused on the regulation and growth-relatedness of lipoprotein biogenesis in McA-RH7777 cells. We have observed that growing cells are considerably more responsive than confluent cells to inhibitors and stimulants of lipoprotein production, and that triacylglycerol synthesis and triacylglycerol secretion efficiency are differentially sensitive to diffusible factors and to changes in cell proximity [26] . Supplementation of growing
McA-RH7777 cells with oleic acid (OA; C18 In 9) stimulates both triacylglycerol synthesis and VLDL-triacylglycerol secretion, with dose-dependent effects on the efficiency of VLDLtriacylglycerol secretion [24] . In contrast, linoleic acid (C18:2n-6) is a potent inhibitor of both processes [24] . We therefore felt that McA-RH7777 cells might provide a sensitive model for investigating the influence of n -3 PUFAs on hepatocyte triacylglycerol synthesis and secretion in a rapidly growing system. In this paper we report that the n -3 PUFA eicosapentaenoic acid (EPA; C20:5n-3) selectively inhibits triacylglycerol secretion by McA-RH7777 cells in the context of sustained triacylglycerol synthesis, resulting in exaggerated intracellular triacylglycerol accumulation compared with cells given OA, and that this phenomenon is accompanied by inhibition of cell growth. This work was presented in preliminary form at the 60th Scientific Sessions of the American Heart Association [26a] .
EXPERIMENTAL Materials
Fetal-bovine serum (FBS) was purchased from Hazelton Laboratories (Lenexa, KS, U.S.A.) and heat-inactivated according to the supplier's recommendations before use. EPA (allcis-5,8,1 1,14,17-eicosapentaenoic acid; -90 % pure), (OA octadec-9-enoic acid), BSA (Cohn fraction V) and BF3/methanol were purchased from Sigma. Cell-culture media and related supplies were purchased from Gibco. [ Preparation of fatty acid-BSA complexes BSA was rendered free of fatty acid by the method of Chen [27] . Non-esterified fatty acids (NEFA) were complexed with treated BSA at a molar ratio of 4: 1 by co-sonication in phosphate-buffered saline (10 mM-sodium phosphate/0.15 MNaCl, pH 7.4) under a N2 atmosphere to prevent peroxidation. As additional precautions we stored unopened ampoules of fatty acid at -30°C in a vacuum desiccator in the dark; only freshly opened ampoules were used for each experiment, and we discarded the unused contents of opened ampoules; and fatty acid-BSA complexes were kept under N2 in darkness until the time of addition to the medium.
Cell growth and labelling
The rat hepatoma cell line McA-RH7777 was obtained from the American Type Culture Collection (CRL 1601) and maintained in basal medium (Dulbecco's modified Eagle's medium supplemented with 10% FBS, 2 mM-glutamine, 100 IU of penicillin/ml and 100,tg of streptomycin/ml) at 37°C in a humidified atmosphere with 5% CO2. It was previously established in our laboratory that McA-RH7777 cells maintain significantly greater rates of growth and protein synthesis, as well as increased protein secretion, in medium containing FBS than in serum-deficient medium; moreover, the specific effects of fatty acid supplementation are not affected by the presence of bovine lipoprotein components or other undefined elements present in FBS [24] . We therefore exposed the cells to supplemental fatty acids and performed all labelling studies in medium containing FBS. Because EPA is resistant to peroxidation in aqueous solution [28] , since commercial antioxidants may perturb lipoprotein structure or function [29] , and because we empirically established that our medium formulation prevents peroxidation ofsupplemental fatty acids (see the Results section), no exogenous antioxidants were added to medium other than the mixture provided by FBS (i.e. vitamin E, transferrin and ceruloplasmin, in addition to other minor species).
Cells were plated at a density of (1-2) x 104 cells/cm2. After 2 days of growth in basal medium, the medium was replaced with fresh basal medium supplemented with fatty acid-BSA complex, as either EPA or OA at the final concentrations of supplemental fatty acid indicated in the Figures and their legends. Control cultures received an equivalent dose of fatty-acid-free BSA subjected to mock conditions of sonication, storage and handling. Cell counts were determined during the growth period with a haemocytometer; there was an excellent correlation between cell number and total cell protein per dish (r2 = 0.947).
For labelling experiments, cells were first exposed to fatty acid-BSA complex or to BSA alone for 24 h, and then labelled with [14C]glycerol (1 , uCi/dish) for an additional 24 h without otherwise changing the incubation conditions. Cells and media were harvested and analysed separately. Triacylglycerols were separated from total lipid extracts by t.l.c. [30] , and [14C]glycerol incorporation was determined by liquid-scintillation counting. Cell protein mass was measured by the method of Lowry et al. [31] .
Assay for fatty acid peroxidation products Samples of medium (10 ml each) and cell lysates (equivalent to approx. 107 cells) from growing cultures supplemented for 48 h with OA-BSA complex, EPA-BSA complex or BSA alone were adjusted to pH 3.0 with HC1 and extracted five times with nhexane. These extracts were dried over Na24 and concentrated to a final volume of 0.1 ml by partial evaporation under N2' U.v. spectra were obtained from 200 to 500 nm in a Beckman model UV5230 scanning spectrophotometer.
Chemical analysis
For preparative-scale experiments without radiolabelling, cells were plated at a density of (1-2) x 104 cells/cm2 and grown in 75 cm2 Corning Costar culture flasks for 2 days in 10 ml of basal medium. This medium was replaced with fresh basal medium supplemented with OA-BSA complex, EPA-BSA complex, mixtures of the two, or with BSA alone, and then grown for an additional 2 days. Total lipid was extracted by the Folch method, total triacylglycerols were purified by preparative t.l.c., and triacylglycerol-associated fatty acids (TGFA) were analysed by trans-esterification and g.l.c. as previously described [30] . Individual fatty acid methyl ester species were identified by retention time as compared with standards composed of a saturated series (C16, C18, C20, C22, C24), an n -9 monounsaturated series (C16, C18, C20, C22, C24)' a mixture of long-chain saturated and unsaturated species (C18:0, C18: ln-9 C18: 2n6' C18: 3n-3' C20:4n-6), The growth of McA-RH7777 cells in basal medium has been well characterized in our laboratory [26] , as well as by other investigators [23, 32] . It Differences between any two growth rates were significant at 72 h (P < 0.05).
Because polyunsaturated fatty acids may undergo peroxidation to generate potentially cytotoxic products, in early experiments we examined concentrated n-hexane extracts of both media and cell lysates from cultures grown with and without fatty acid supplementation for the presence of conjugated dienes by u.v. scanning spectrophotometry. Of the many accepted techniques for evaluating lipid peroxidation, we chose this as a convenient and reliable way to detect early yet persistent products of the peroxidation process [33] [34] [35] , with an estimated sensitivity in the low nanomolar range in our 100-fold-concentrated extracts [36, 37] , and hence in the picomolar range with respect to the samples before extraction. Except for a minor peak at 205 nm representing EPA in the EPA-treated cultures, all the extracts gave essentially identical absorption spectra. Specifically, none of the extracts contained detectable material with an absorption maximum between 230 and 240 nm that would suggest the presence of conjugated dienes. Since we found no spectrophotometric evidence of fatty acid peroxidation in our own system, we conclude that the antioxidant mixture contributed to the medium by FBS is effective, and we consider it highly unlikely that the growth-inhibitory effects of EPA on McA-RH7777 cultures reflect free-radical-mediated cell injury. given level of total supplemental NEFA the mole fraction of EPA was varied from 0.1 to 0.9. Net triacylglycerol synthesis and secretion were assessed as for Fig. 2 . At EPA mole fractions of 0.5 or less, there was no significant inhibition of triacylglycerol secretion compared with cells given an equivalent supplemental concentration of OA only, regardless of the level of total supplemental NEFA. However, at EPA mole fractions greater than 0.5, the degree of inhibition of triacylglycerol secretion resembled that of cells supplemented with an equivalent dose of EPA alone (results not shown).
Fatty acyl composition of triacylglycerols
The observations presented so far suggest that EPA causes some post-synthetic derangement in hepatoma triacylglycerol metabolism, either at the level of assembling triacylglycerol molecules into lipoprotein particles or during the secretion of these particles from the cell. Although our labelling data point to an exaggerated intracellular accumulation of newly synthesized triacylglycerol in EPA-supplemented cultures, they do not distinguish among the many possible chemical forms of the accumulated triacylglycerol. We therefore determined the fatty acyl composition of total triacylglycerol isolated from nonlabelled media and cell lysates (Fig. 3) . Under control conditions 22 % of medium TGFA was OA; medium-chain saturated fatty acids comprised about 30 %, and the remainder were mostly medium-and long-chain saturated and unsaturated species. Control cellular triacylglycerol was composed of 52 % OA, 17 % palmitate, and smaller amounts of other species (Fig. 3a) . Cultures supplemented with 330 /LM-oleic acid displayed a TGFA composition resembling that of control cultures, except for a greater proportion of OA in both medium and cells (Fig. 3a) . The medium triacylglycerols contained 29% OA and lesser amounts of other medium-chain and long-chain fatty acids; cellular triacylglycerols contained 62% OA, with a variety of fatty acids making up the remainder.
The pattern of TGFA composition in cultures receiving either 165 1M-or 330,M-EPA was markedly different from that of control or OA-supplemented cells (Fig. 3b) . Medium TGFA (TGFAm) from 165 ,tM-or 330 /tM-EPA-supplemented cells contained predominantly palmitate (26 and 22 % respectively) and OA (14 and 21 % respectively), whereas EPA and its chainelongated metabolite DHA made up only a small fraction of recovered fatty acyl residues in medium triacylglycerols (6 and 3 % EPA and 4 and 2 % DHA respectively). In contrast, cellular TGFA (TGFAC) from both 165SM-and 330/M-EPA-treated cells contained mainly EPA (33 and 37 % respectively) and DHA (24 and 13 % respectively).
We also determined the TGFA composition for cultures treated with EPA-dominant (supplemental EPA: OA molar ratio = 2: 1; designated medium C) and OA-dominant (supplemental EPA:OA = 1:2; designated medium D) mixtures at an overall supplemental fatty acid concentration of 330 luM (Fig. 3c) . The TGFA from cultures treated with the EPA-dominant medium C resembled that from cultures treated with EPA alone, but had a greater percentage of OA in both medium and cellular triacylglycerol. The cellular triacylglycerol from medium C cultures, like those treated with EPA alone, contained large proportions of EPA (18%) and DHA (22%); but, unlike cells treated with EPA alone, those supplemented with the medium C mixture had predominantly OA (38 %) in TGFAC. Cells treated with the OA-dominant medium D behaved more like cells treated with OA alone. TGFAC from medium D cultures contained a larger proportion of OA (56 %) than the cultures treated with medium C, and EPA and DHA made relatively small contributions to TGFAC in medium D cultures (5 and 10% respectively). Despite their differences in TGFAC composition, however, neither cultures exposed to medium C nor those exposed to medium D were found to have substantial proportions of n -3 fatty acids in TGFAm. TGFAm from the cultures exposed to medium C contained predominantly OA (16%) and palmitate (11 %), but little EPA (5 %) or DHA (2 %). Likewise, TGFAm from cultures receiving medium D contained predominantly OA (27 %) but little EPA (4%) or DHA (6%).
It would be easy to interpret these findings, were it not for the fact that in this series of experiments unlabelled medium triacylglycerols probably represent a mixture of triacylglycerol molecules derived from FBS and those secreted de novo by hepatoma cells. We have explored several potential approaches toward resolving this mixture. We initially considered simply subtracting the TGFA species present in non-conditioned basal medium from the corresponding levels in conditioned medium. However, this would give an inaccurate estimate of net TGFA secretion: FBS-derived triacylglycerols, especially molecules from lipoprotein particles damaged during the requisite freezethawing and heat inactivation of FBS, are a ready substrate for rapidly growing cells, and therefore cannot be considered to rest undisturbed in the medium throughout the incubation period.
We have also tested alternative medium formulations for maintaining McA-RH7777 cultures, including decreasing FBS levels, the use of serum-free medium optimized for hepatocyte culture [38, 39] , and the use of lipoprotein-deficient serum instead of whole FBS [24] . Regardless of whether supplemental fatty acids are present or not, we find that these formulations either generally inhibit cell growth and protein secretion as compared with the basal medium described here, or they significantly alter the spectrum of radiolabelled lipoprotein particles secreted by McA-RH7777 cells; moreover, each poses the risk of depleting the medium of antioxidants normally provided by whole FBS.
Having found no practical solution for resolving the TGFA mixture of conditioned media into exogenous and endogenous components without perturbing the culture system as a whole, we offer instead a logical argument based on the initial fatty acid content of medium, inspection of Fig. 3, and Fig. 3) . In medium D, however, greater proportions of total new triacylglycerol-associated EPA and DHA were secreted than of triacylglycerol-associated OA. Moreover, at 330 /M total supVol. 286 plemental fatty acid, the efficiency of secreting newly synthesized triacylglycerol-associated EPA and DHA into the medium increased with the OA content of the supplement (Figs. 3b and  3c) . If the stated hypothesis is correct, these results suggest that McA-RH7777 cells exposed to EPA-dominant mixtures of fatty acid preferentially secrete triacyiglycerol molecules lacking n -3 PUFAs, but that substituting OA for EPA can over-ride and even perhaps reverse this preference in a dose-dependent fashion.
Hypothesis 2: TGFA, at 48 h of incubation represent a mixture of FBS-derived TGFAs and newly produced TGFAs: moreover, either (a) newly produced TGFAs are secreted in the same proportions as they are synthesized, or (b) some TGFAs are secreted in preference to others. If (a) is true, then the relative proportions of new TGFA species appearing in the medium should be identical with those remaining in the cell, i.e. there is no bias in secretion. Since all the triacylglycerol-associated EPA and DHA must come from triacylglycerol production de novo, the amount of new triacylglycerol-associated OA relative to FBS-derived triacylglycerol-associated OA in the medium can be estimated from the ratio of triacylglycerol-associated OA to EPA + DHA in the cells, i.e.
where m denotes medium, c denotes cells, and n -3 includes triacylglycerol-associated EPA and DHA. Using this proportionality, we estimate that new triacylglycerol-associated OA would account for 15% of all medium triacylglycerolassociated OA in medium A, 9 % in medium B, 48 % in medium C and 142 % in medium D. Although the first two values seem reasonable and the third is possible, the fourth is neither. We have met a logical contradiction; therefore, part (a) of the hypothesis must be false for at least one condition of supplementation. In addition, although these estimated percentages of medium triacylglycerol-associated OA attributable to triacylglycerol production de novo do not allow us to say whether triacylglycerol-associated OA or EPA is preferentially secreted in the presence of EPA alone, the cells' ability to secrete triacylglycerol-associated EPA relative to OA at 330 /aM total supplemental fatty acid appears to improve with OA co-supplementation, in a dose-dependent fashion. Thus part (b) of this hypothesis is true, i.e. under some conditions (most notably in medium D) McA-RH7777 cells may alter their efficiency of secreting EPA molecules relative to that of secreting-OA molecules recently incorporated into triacylglycerol.
From our own and other available data, we cannot say with certainty which hypothesis regarding TGFAm is correct, although we favour the second. Nevertheless, regardless of which hypothesis one selects, the TGFAC and the TGFAm data of Fig. 3 together point to reluctant secretion by McA-RH7777 cells in an EPA-rich environment of EPA-containing triacylglycerol molecules relative to those containing OA, but with OA cosupplementation somehow relieving the impairment.
DISCUSSION
In the cultured rat hepatoma McA-RH7777, EPA stimulates triacylglycerol synthesis above basal levels to the same extent as does OA. OA stimulates net triacylglycerol secretion without affecting cell growth; in contrast, EPA is a potent inhibitor of both processes. EPA and its metabolite DHA are evidently suitable substrates for triacylglycerol synthesis in cultures, yet it appears that these cells have difficulty in secreting triacylglycerol molecules containing EPA or DHA unless simultaneously provided with a sufficient quantity of another species of fatty acid, such as OA.
It is generally agreed that EPA inhibits triacylglycerol production by hepatocyte systems, but no consensus has emerged about the mechanisms responsible. Some authors have inferred that n -3 PUFAs both suppress and serve as poor substrates for triacylglycerol synthesis [5, 9, [42] [43] [44] . Others Previously we reported that both synthesis and secretion efficiency of triacylglycerol decline during McA-RH7777 growth in basal medium, through the action or depletion of one or more unidentified diffusible factors in the medium rather than through cell-cell contacts, but that triacylglycerol secretion efficiency is more responsive to these factors than is triacylglycerol synthesis [26] . In that study we also found that orotic acid, a potent hypotriglyceridaemic agent in vivo for rats, selectively inhibits triacylglycerol synthesis in growing McA-RH7777 cells without altering their triacylglycerol secretion efficiency. The results presented here argue that EPA affects McA-RH7777 cells in a manner converse to orotic acid, but similar to the putative growth-related factor(s). Taken together, our findings argue compellingly that triacylglycerol synthesis and triacylglycerol secretion are independently regulated processes. In support of this viewpoint, Otto et al. recently [50] concluded that the inhibitory effects of a fish-oil-containing diet on hepatic triacylglycerol secretion in rats are independent of its effects on triacylglycerol synthesis, and Martin et al. [40] determined that DHA need not inhibit triacylglycerol synthesis in cultured rat hepatocytes in order to decrease their rates of triacylglycerol secretion.
To the best of-our knowledge, we are the first to report that EPA inhibits growth of hepatoma cells. There is, however, ample precedent for this finding in other cell types: Marine n-3 PUFAs have been found to depress growth and growth-related phenomena in other neoplasms [53] [54] [55] [56] [57] , in vascular cells [58] [59] [60] , and even in cultured normal human skin fibroblasts [61] . Although the mechanisms of growth inhibition are not known, changes in prostanoid metabolism in themselves are not thought to be responsible [58, 59] , nor is it likely that free-radical-mediated cell injury accounts for the anti-proliferative properties of EPA. In our system, careful handling of fatty acids during preparation of fatty acid: BSA complexes and the presence of FBS-supplied antioxidants in basal medium were sufficient to prevent detectable peroxidation of EPA. Moreover, no evidence of decreased cell viability (as a likely consequence of free-radical injury) has been found in cultured rat hepatocytes exposed to DHA [40] or in cultured CaCo-2 human intestinal cells exposed to EPA [62] ; and Tisdale & Beck found that neither DHA nor linoleic acid (both at least as susceptible to peroxidation as EPA [28] ) showed the growth-inhibiting activity of EPA [54] .
We are also the first to suggest an association between the antiproliferative and hypotriglyceridaemic effects of EPA. Such a connection should not be surprising, in light of reported parallel inhibitions of growth and other differentiated functions in cells exposed to EPA [54, 60] . However, it is understandable that this particular association was not heretofore recognized in other triacylglycerol producing model systems. Hepatocyte turnover in vivo is normally slow, and hepatocytes do not grow during the usual periods of liver perfusion ex vivo. Primary cultures of adult-rat hepatocytes grow sluggishly, with a doubling time under optimal culture conditions of about 5 days [63, 64] ; this is significantly longer than the usual periods chosen for exposure to EPA or DHA in vitro [40, 42, 46, 65] . Other investigators using triacylglycerol-producing neoplastic cell types have examined the effects of n-3 PUFAs only in confluent or near-confluent cultures [45, 62, 66, 67] . In contrast with these other systems, exponentially growing McA-RH7777 cultures exhibit a cell doubling time of only about I day [26] ; and unlike HepG2 cells, which do not normally synthesize or secrete significant amounts of VLDL triacylglycerol in the absence of exogenous fatty acid [68, 69] , McA-RH7777 cells vigorously produce triacylglycerolrich lipoproteins even under basal conditions. Since decreases in cell growth or in triacylglycerol production are most easily measured in systems displaying high basal rates of each, McA-RH7777 cultures provide an attractive caricature of the interplay between these phenomena. Because growth requires ongoing membrane synthesis, and because rapidly growing hepatoma cells more actively synthesize and secrete triacylglycerol-rich lipoproteins than do sub-confluent or confluent cultures, any functional consequences of structurally altered membrane lipids and/or nascent lipoprotein particles might be more apparent in this system than in other model hepatocytes.
With regard to possible mechanisms, in McA-RH7777 cultures it may be that growth and triacylglycerol secretion in the presence of EPA are causally related, if only in a trivial way: if VLDL secretion is generally driven by some mechanism coupled to cell growth, as our previous work implies [26] , any factor that inhibits growth might be expected to inhibit triacylglycerol secretion in parallel. For example, were EPA to inhibit the synthesis or release of some autocrine hepatocytic mitogen (borrowing from suggestions by Sarris et al. [58] ), McA-RH7777 cells might interrupt triacylglycerol secretion merely because they have stopped growing. Alternatively, growth and triacylglycerol secretion could be concurrent yet coincidental victims of EPA-or DHA-induced alterations in membrane phospholipid structure and function [62, 65, 70] or in pathways of signal transduction via second messengers [71] . The selective inhibition of triacylglycerol-rich lipoprotein secretion by n-3 PUFAs, without affecting secretion of other major protein products such as albumin [67] , further suggests that organelle compartments thought to be specifically involved in plasma lipoprotein assembly and transport [72] might be particularly sensitive to such intracellular alterations.
Besides influencing the mechanisms governing triacylglycerol secretion in general, n -3 PUFAs apparently also perturb some intrinsic property of the triacylglycerol molecules into which they are incorporated. Both the TGFA analyses presented here and other groups' analyses of intracellular and secreted triacylglycerols obtained from cultured rat hepatocytes incubated with EPA or DHA [40, 42] argue that under certain circumstances triacylglycerol molecules containing n-3 fatty acids are not readily secreted from the cell. Martin et al. [40] proposed that the intracellular partitioning of newly synthesized triacylglycerols between lipoprotein assembly and cytosolic accumulation favours retention of DHA-containing molecules. Our results support and extend their proposal by demonstrating that triacylglycerol partitioning responds to changing conditions of fatty acid supplementation, such that the balance between retention and secretion of triacylglycerol-associated EPA and DHA depends on the availability of other fatty acyl species.
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At present we can only speculate about mechanisms that could account for such specific effects of n -3 PUFAs. One possibility could be that McA-RH7777 cells (and others in which n -3 PUFAs are suitable substrates) may incorporate one, two or three molecules of EPA or DHA into a particular molecule of triacylglycerol, depending on the relative abundance of different fatty acid species. In contrast, either packaging of triacylglycerols into nascent lipoprotein particles, or subsequent secretion of triacylglycerol-rich lipoproteins themselves, may favour molecules containing one or two fatty acyl species other than n -3 PUFAs. When the available fatty acid pool is EPA-or DHA-dominant, the likelihood of synthesizing a triacylglycerol molecule containing two or three n -3 PUFAs is high, yet these cannot be readily secreted; in addition to any general impairment of triacylglycerol secretion effected by changes in membrane structure and -function or signal transduction, triacylglycerolassociated EPA and DHA are retained disproportionately by the cell. On the other hand, when the available pool is OA-dominant, newly synthesized triacylglycerol molecules containing at most one EPA or DHA acyl group would predominate, so that the apparent secretion efficiency of triacylglycerol-associated EPA and DHA is relatively preserved. This scenario is consistent with the notion of stereoselective triacylglycerol partitioning invoked by Martin et al. [40] . Moreover, if the computer-modelling studies of diacylglycerol conformation by Applegate & Glomset [73, 74] may be extrapolated to triacylglycerol structure, the packing of EPA-or DHA-rich triacylglycerols into a nascent lipoprotein core should differ substantially from that ofmolecules containing few or no n -3 fatty acyl groups. These speculations, however reasonable, remain to be tested empirically.
As a final comment, it is not yet known whether our findings regarding McA-RH7777-cell growth are relevant to the effects of fish-oil fatty acids in vivo. We are hesitant to extrapolate the behaviour of hepatoma cells given an EPA-predominant fatty acid environment in culture to hepatic function in intact subjects for whom maximal plasma levels of EPA, as well as its proportion of the plasma NEFA pool, are considerably lower. Nevertheless, we are concerned that antiproliferative effects of n -3 PUFAs have been observed in vivo [58, 59] , and that fish-oil treatment is finding its way into paediatric use [75] . Until the effects of fishoil n -3 PUFAs on hepatocyte proliferation are better understood, perhaps they should be administered cautiously in clinical situations where continued hepatic growth or regeneration is desirable.
